Autolus Therapeutics plc (AUTL)

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $10.50M in the twelve months ending June 30, 2024, up 40.22% year-over-year. In the year 2023, Autolus Therapeutics had annual revenue of $1.70M, down -73.30%.

• Revenue (ttm): $10.50M
• Revenue Growth: +40.22%
• P/S Ratio: 76.25
• Revenue / Employee: $22,287
• Employees: 471
• Market Cap: 992.53M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.70M	-4.66M	-73.30%
Dec 31, 2022	6.36M	4.03M	172.96%
Dec 31, 2021	2.33M	615.00K	35.86%
Dec 31, 2020	1.72M	-1.19M	-41.02%
Dec 31, 2019	2.91M	1.44M	97.55%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.